AstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been given an average recommendation of “Buy” by the ten ratings firms that are currently covering the company, Marketbeat.com reports. One equities ...

Today we will run through one way of estimating the intrinsic value of AstraZeneca PLC (LON:AZN) by projecting its future ...

AstraZeneca PLC ADR closed 13.33% below its 52-week high of $87.68, which the company achieved on August 30th.

AstraZeneca has been urging sports fans to “Get Body Checked Against Cancer” in a campaign launched in collaboration with the ...

AstraZeneca PLC (NASDAQ:AZN), a British-Swedish pharmaceutical company, develops prescription medicines across key areas like ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other ...

AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), ...

AstraZeneca Pharma India has announced that the Company has received permission from the CentralDrugs Standard Control ...

AstraZeneca PLC (LSE:LON:AZN) has reported that Pascal Soriot, the company’s Chief Executive Officer, acquired 89,962 ordinary shares following the vesting of a performance-based award on Monday.